Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut pathogen colonization refers to the process by which pathogenic microorganisms—such as bacteria like *Salmonella*, *Clostridioides difficile*, or antimicrobial-resistant *Klebsiella pneumoniae*—establish and proliferate within the gastrointestinal tract[1][2][3][4][5]. Colonization is modulated by factors including microbiota composition, immune responses, availability of nutrients, host genetic factors, and external pressures such as antibiotics. Healthy gut microbiota exert colonization resistance, directly killing pathogens, competing for resources, and stimulating protective immune responses. Disruption of this balance (e.g., following antibiotics, dietary change, or illness) increases susceptibility to pathogen overgrowth, leading to infection and associated disease states[1][2][4][5].
Disruption or restoration of colonization resistance by antibiotics or probiotics; Direct inhibition or killing of pathogens (*via* antimicrobials); Modification of microbiota composition (*via* transplantation or bacteriophage therapy)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut pathogen colonization.